These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

852 related items for PubMed ID: 17461860

  • 21. Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.
    Moh R, Danel C, Messou E, Ouassa T, Gabillard D, Anzian A, Abo Y, Salamon R, Bissagnene E, Seyler C, Eholié S, Anglaret X.
    AIDS; 2007 Nov 30; 21(18):2483-91. PubMed ID: 18025885
    [Abstract] [Full Text] [Related]

  • 22. Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
    Laurichesse JJ, Persoz A, Theodorou I, Rouzioux C, Delfraissy JF, Meyer L.
    HIV Med; 2007 May 30; 8(4):213-9. PubMed ID: 17461848
    [Abstract] [Full Text] [Related]

  • 23. The impact of malnutrition on survival and the CD4 count response in HIV-infected patients starting antiretroviral therapy.
    Paton NI, Sangeetha S, Earnest A, Bellamy R.
    HIV Med; 2006 Jul 30; 7(5):323-30. PubMed ID: 16945078
    [Abstract] [Full Text] [Related]

  • 24. Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs.
    Verguet S, Lim SS, Murray CJ, Gakidou E, Salomon JA.
    J Infect Dis; 2013 Jan 01; 207(1):72-9. PubMed ID: 23100567
    [Abstract] [Full Text] [Related]

  • 25. Setting a minimum threshold CD4 count for initiation of highly active antiretroviral therapy in HIV-infected patients.
    Ho C, Lee S, Wong Kh, Cheng L, Lam M.
    HIV Med; 2007 Apr 01; 8(3):181-5. PubMed ID: 17461862
    [Abstract] [Full Text] [Related]

  • 26. Later cART initiation in migrant men from sub-Saharan Africa without advanced HIV disease in France.
    de Monteynard LA, Dray-Spira R, de Truchis P, Grabar S, Launay O, Meynard JL, Khuong-Josses MA, Gilquin J, Rey D, Simon A, Pavie J, Mahamat A, Matheron S, Costagliola D, Abgrall S, French Hospital Database on HIV.
    PLoS One; 2015 Apr 01; 10(3):e0118492. PubMed ID: 25734445
    [Abstract] [Full Text] [Related]

  • 27. CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy.
    Wolbers M, Battegay M, Hirschel B, Furrer H, Cavassini M, Hasse B, Vernazza PL, Bernasconi E, Kaufmann G, Bucher HC, Swiss HIV Cohort Study.
    Antivir Ther; 2007 Apr 01; 12(6):889-97. PubMed ID: 17926643
    [Abstract] [Full Text] [Related]

  • 28. Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.
    Lapadula G, Torti C, Maggiolo F, Casari S, Suter F, Minoli L, Pezzoli C, Di Pietro M, Migliorino G, Ouiros-Roldan E, Ladisa N, Sighinolfi L, Costarelli S, Carosi G, Italian MASTER Cohort.
    Antivir Ther; 2007 Apr 01; 12(6):941-7. PubMed ID: 17926648
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
    Li H, Zheng YH, Shen Z, Liu M, Liu C, He Y, Chen J, Ou QY, Huang ZL.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 13; 87(42):2973-6. PubMed ID: 18261327
    [Abstract] [Full Text] [Related]

  • 31. Initiation of antiretroviral therapy in advanced AIDS with active tuberculosis: clinical experiences from Thailand.
    Sungkanuparph S, Manosuthi W, Kiertiburanakul S, Vibhagool A.
    J Infect; 2006 Mar 13; 52(3):188-94. PubMed ID: 15992932
    [Abstract] [Full Text] [Related]

  • 32. Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.
    Soria A, Porten K, Fampou-Toundji JC, Galli L, Mougnutou R, Buard V, Kfutwah A, Vessière A, Rousset D, Teck R, Calmy A, Ciaffi L, Lazzarin A, Gianotti N.
    Antivir Ther; 2009 Mar 13; 14(3):339-47. PubMed ID: 19474468
    [Abstract] [Full Text] [Related]

  • 33. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
    Skiest DJ, Su Z, Havlir DV, Robertson KR, Coombs RW, Cain P, Peterson T, Krambrink A, Jahed N, McMahon D, Margolis DM, AIDS Clinical Trials Group 5170 Study Team.
    J Infect Dis; 2007 May 15; 195(10):1426-36. PubMed ID: 17436222
    [Abstract] [Full Text] [Related]

  • 34. Long-term consequences of treatment interruptions in chronically HIV-1-infected patients.
    Wolf E, Hoffmann C, Procaccianti M, Mosthaf F, Gersbacher E, Ulmer A, Karwat M, Brust J, Schuster D, Jaegel-Guedes E, Jaeger H.
    Eur J Med Res; 2005 Feb 28; 10(2):56-62. PubMed ID: 15817423
    [Abstract] [Full Text] [Related]

  • 35. Mortality and morbidity among HIV type-1-infected patients during the first 5 years of a multicountry HIV workplace programme in Africa.
    Van der Borght SF, Clevenbergh P, Rijckborst H, Nsalou P, Onyia N, Lange JM, de Wit TF, Van der Loeff MF.
    Antivir Ther; 2009 Feb 28; 14(1):63-74. PubMed ID: 19320238
    [Abstract] [Full Text] [Related]

  • 36. Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy.
    Peuchant O, Thiébaut R, Capdepont S, Lavignolle-Aurillac V, Neau D, Morlat P, Dabis F, Fleury H, Masquelier B, ANRS CO3 Aquitaine Cohort.
    AIDS; 2008 Jul 31; 22(12):1417-23. PubMed ID: 18614864
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation?
    Newell ML, Patel D, Goetghebuer T, Thorne C, European Collaborative Study.
    J Infect Dis; 2006 Apr 01; 193(7):954-62. PubMed ID: 16518757
    [Abstract] [Full Text] [Related]

  • 40. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
    Masiá M, Padilla S, Bernal E, Almenar MV, Molina J, Hernández I, Graells ML, Gutiérrez F.
    Clin Ther; 2007 Jul 01; 29(7):1448-55. PubMed ID: 17825696
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 43.